GGrantIndex
Sort

89,613 grants matching depression

ARIC Neurocognitive Study (ARIC-NCS)

$1,294,335
David J Couper · Univ Of North Carolina Chapel Hill · U01 · FY2011 · HL

The Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older Adults (BRIO)

$1,294,013
Nathan K Lebrasseur · Mayo Clinic Rochester · R01 · FY2024 · AG

Development of MRI Techniques for Drug-Abuse Applications

$1,294,012
Yihong Yang · National Institute On Drug Abuse · ZIA · FY2018 · DA

Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma

$1,293,841
Tara M Brinkman · St. Jude Children'S Research Hospital · R61 · FY2022 · CA

NIMHD-Research Center of Excellence at the University of Maryland

$1,293,634
Stephen B. Thomas · Univ Of Maryland, College Park · P60 · FY2011 · MD

Molecular Mechanisms of Estrogen Action in Sex Organ Development

$1,293,591
Christina Tu Teng · Environmental Health Sciences · Z01 · FY2007 · ES

A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti - 2

$1,293,055
Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · HL

Predicting and Preventing Neglect in Teen Mothers

$1,292,452
University Of Notre Dame · R01 · FY2005 · HD

Project 1 -- MIDUS Survey Project

$1,292,364
Carol D. Ryff · University Of Wisconsin-Madison · U19 · FY2024 · AG

Bioanalysis, Drug Metabolism and New Drug Discovery

$1,292,299
Josephine Earley · National Institute On Aging · ZIA · FY2018 · AG

Translational pharmacoepidemiology: neuroprotection and neurotoxicity of antihypertensives and strong anticholinergics

$1,292,161
Shelly L Gray · Kaiser Foundation Research Institute · U19 · FY2025 · AG

Molecular Elements, Neurocircuits and Mental Illness

$1,291,910
University Of Michigan At Ann Arbor · P01 · FY2003 · MH

Molecular tools for precise manipulation of defined synaptic connections

$1,290,713
Alice Y Ting · Stanford University · R01 · FY2025 · MH

Phase III COBRE: Multimodal Imaging of Neuropsychiatric Disorders (MIND)

$1,290,517
Vincent P Clark · The Mind Research Network · P30 · FY2019 · GM

Combined Behavioral & Analgesic Trial for Fibromyalgia (COMBAT-FM)

$1,290,494
Dennis C. Turk · University Of Washington · R01 · FY2011 · AR

Prospective meta-analyses of drug-gene interactions: CHARGE GWAS consortium

$1,290,419
Bruce M Psaty · University Of Washington · R01 · FY2013 · HL

Developmemt of Novel Treatments for Nicotine Addiction

$1,290,333
Linda P Dwoskin · University Of Kentucky · U19 · FY2007 · DA

UZIMA-DS: UtiliZing health Information for Meaningful impact in East Africa through Data Science

$1,289,993
Amina Abubakar Ali · Aga Khan University (Kenya) · U54 · FY2022 · TW

Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-1 in Neural and Cognitive Functions

$1,289,713
Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD

Developmemt of Novel Treatments for Nicotine Addiction

$1,289,142
Linda P Dwoskin · University Of Kentucky · U19 · FY2006 · DA

Studies Of Central Nervous System Functional Anatomy

$1,289,044
Miles A. Herkenham · National Institute Of Mental Health · ZIA · FY2014 · MH

Neurobiological drivers of mobility resilience: the dopaminergic system

$1,288,819
Caterina Rosano · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · AG

Predictors of Treatment Response Relapse and Recurrence in Major Depression

$1,288,719
W. Edward Craighead · Emory University · R01 · FY2008 · MH

John F. Kennedy Center for Mental Retardation

$1,288,600
Elisabeth May Dykens · Vanderbilt University · P30 · FY2008 · HD

Trial of Exercise and Lifestyle (TEAL) in Women with Ovarian Cancer

$1,288,540
Melinda L Irwin · Yale University · U01 · FY2025 · CA